Poland· PL-100141826

Liść Brusznicy

A medicinal product containing vitis ideae folium, registered in Poland by Zakład Konfekcjonowania Ziół "FLOS" Elżbieta i Jan Głąb spółka jawna.

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLiść BrusznicyATC—REGISTER NO.PL-100141826PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Vitis ideae folium
Manufacturer
Zakład Konfekcjonowania Ziół "FLOS" Elżbieta i Jan Głąb spółka jawna
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990628193
  • gtin
    05909990628209

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ff8f215a-bc4a-4f00-a3fa-48145c0a9d2b
GET /v1/drugs/ff8f215a-bc4a-4f00-a3fa-48145c0a9d2b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Zioła do zaparzania",
  "source": "urpl",
  "strength": "-",
  "packaging": "05909990628193 ¦ OTC ¦ 1635\n1 op. 25 g\n05909990628209 ¦ OTC ¦ 17028\n1 op. 50 g",
  "substance": "Vitis ideae folium 100 g/100 g",
  "common_name": "Vitis ideae folium",
  "pl_product_id": "100141826",
  "pozwolenie_nr": "IL-0807/LN",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about vitis ideae folium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.